Tony E. Hugli
#113,729
Most Influential Person Now
Tony E. Hugli's AcademicInfluence.com Rankings
Tony E. Hugliphilosophy Degrees
Philosophy
#4854
World Rank
#7515
Historical Rank
Logic
#2233
World Rank
#3180
Historical Rank
Tony E. Huglibiology Degrees
Biology
#6456
World Rank
#9175
Historical Rank
Immunology
#335
World Rank
#348
Historical Rank
Download Badge
Philosophy Biology
Why Is Tony E. Hugli Influential?
(Suggest an Edit or Addition)Tony E. Hugli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. (1981) (1153)
- Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. (1978) (573)
- Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. (1972) (484)
- Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. (1978) (472)
- Anaphylatoxins: C3a and C5a. (1978) (431)
- C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation (1995) (294)
- Release of histamine from rat mast cells by the complement peptides C3a and C5a. (1975) (285)
- Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. (1992) (261)
- Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. (1978) (219)
- Requirement and role of C5a in acute lung inflammatory injury in rats. (1996) (212)
- Endotoxin-induced shock in the rat. A role for C5a. (1989) (192)
- Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. (1983) (183)
- Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. (1976) (169)
- Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury (1994) (168)
- The alternative pathway C3/C5 convertase: chemical basis of factor B activation. (1979) (166)
- Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study (2001) (164)
- Characterization of Complement Anaphylatoxins and Their Biological Responses (1998) (162)
- Complement factors and their receptors. (1997) (161)
- C5a-mediated release of interleukin 6 by human monocytes. (1990) (159)
- Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment1 (2001) (156)
- Biochemistry and biology of anaphylatoxins. (1986) (156)
- Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. (1997) (153)
- Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. (1994) (153)
- Structure and function of C3a anaphylatoxin. (1990) (145)
- Structure and function of the anaphylatoxins. (1984) (145)
- Peptidergic pathway in human skin and rat peritoneal mast cell activation. (1994) (143)
- Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. (1984) (141)
- Techniques in Protein Chemistry (1989) (139)
- Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. (1999) (133)
- C4a: the third anaphylatoxin of the human complement system. (1979) (133)
- Human anaphylatoxin (C3a) from the third component of complement. Primary structure. (1975) (133)
- Structure and function of the anaphylatoxins (1985) (130)
- Structural changes accompanying enzymatic activation of human Hageman factor. (1974) (129)
- Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. (1983) (128)
- Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. (1984) (128)
- A modified method for chemotaxis under agarose. (1979) (127)
- Early Local Generation of C5a Initiates the Elicitation of Contact Sensitivity by Leading to Early T Cell Recruitment1 (2000) (124)
- Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg). (1999) (123)
- Human C5a and C5a analogs as probes of the neutrophil C5a receptor. (1980) (122)
- Microvascular effects of anaphylatoxins C3a and C5a. (1985) (122)
- Pulmonary injury induced by C3a and C5a anaphylatoxins. (1980) (121)
- Role of cell surface contact in the kinetics of superoxide production by granulocytes. (1983) (121)
- Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis (1996) (120)
- The activation of human complement component C5 by a fluid phase C5 convertase. (1983) (118)
- Interleukin-6 and interstitial cystitis. (1994) (117)
- The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. (1995) (113)
- Anaphylatoxin generation in multisystem organ failure. (1984) (111)
- Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). (1985) (109)
- Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. (1979) (108)
- Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. (1982) (104)
- Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. (1992) (104)
- A mechanism of action for anaphylatoxin C3a stimulation of mast cells. (1992) (103)
- Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. (1988) (102)
- C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. (2000) (99)
- C5a-dependent up-regulation in vivo of lung vascular P-selectin. (1997) (98)
- Anaphylactic actions of platelet-activating factor. (1981) (98)
- Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. (1993) (95)
- Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. (1977) (93)
- Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. (1985) (91)
- The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. (1981) (89)
- Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. (1983) (84)
- Familial carboxypeptidase N deficiency. (1980) (83)
- Purification and partial characterization of human and porcine C3a anaphylatoxin. (1975) (82)
- The molecular architecture of human complement component C6. (1989) (82)
- Demonstration of a specific C3a receptor on guinea pig platelets. (1988) (82)
- Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. (1994) (80)
- Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. (1983) (80)
- Anaphylatoxin-mediated regulation of the immune response. I. C3a- mediated suppression of human and murine humoral immune responses (1982) (79)
- Heat-induced fragmentation of human alpha 2-macroglobulin. (1979) (78)
- Biologic activity of synthetic analogues of C5a anaphylatoxin. (1992) (75)
- Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. (1999) (75)
- Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. (1977) (72)
- The active site of C3a anaphylatoxin. (1980) (72)
- Designing synthetic superagonists of C3a anaphylatoxin. (1991) (71)
- Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. (1995) (71)
- C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. (1987) (69)
- Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. (1981) (69)
- Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein. (1989) (68)
- Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity. (1981) (67)
- Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide. (1984) (66)
- Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function* (1999) (64)
- The extraction of leukotrienes (LTC4, LTD4, and LTE4) from tissue fluids: the metabolism of these mediators during IgE-dependent hypersensitivity reactions in lung. (1983) (64)
- Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. (1983) (62)
- Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. (1999) (62)
- The Pancreas as a Source of Cardiovascular Cell Activating Factors (2000) (60)
- Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils. (1984) (58)
- Complete primary structure of human C4a anaphylatoxin. (1981) (58)
- C5a- and tumor necrosis factor-alpha-induced leukocytosis occurs independently of beta 2 integrins and L-selectin: differential effects on neutrophil adhesion molecule expression in vivo. (1995) (56)
- A New Hypothesis for Microvascular Inflammation in Shock and Multiorgan Failure: Self‐Digestion by Pancreatic Enzymes (2005) (55)
- Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels. (1984) (54)
- Effects of the anaphylatoxins on circulation. (1987) (54)
- Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5 (1996) (54)
- Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. (1992) (53)
- Quantitative comparisons of neutrophil chemotaxis in four animal species. (1980) (51)
- C3a-induced contraction of guinea pig lung parenchyma: role of cyclooxygenase metabolites. (1983) (51)
- Isolation and characterization of insoluble proteins of the synaptic plasma membrane. (1968) (51)
- Mechanisms and mediators of neutrophilic leukocytosis. (1994) (50)
- PANCREATIC ENZYMES GENERATE CYTOTOXIC MEDIATORS IN THE INTESTINE (2007) (49)
- Multiple epithelial cell-derived factors enhance neutrophil survival. Regulation by glucocorticoids and tumor necrosis factor-alpha. (1999) (48)
- Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response. (1981) (48)
- Spectrophotometric assay of 2',3'-cyclic nucleotide 3'-phosphohydrolase: application to the enzyme in bovine brain. (1973) (47)
- C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils. (1990) (47)
- Characterization of the human neutrophil response to sex pheromones from Streptococcus faecalis. (1989) (47)
- Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. (1990) (47)
- Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan. (1986) (46)
- Plasma activation during splanchnic arterial occlusion shock. (2000) (46)
- Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus (1985) (46)
- Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement. (1980) (45)
- Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation. (1998) (45)
- Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. (1985) (43)
- Circular dichroism of C3a anaphylatoxin. Effects of pH, heat, guanidinium chloride, and mercaptoethanol on conformation and function. (1975) (43)
- Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene (1997) (42)
- Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus (1983) (41)
- Chemotactic mediator requirements in lung injury following skin burns in rats. (1999) (41)
- Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. (1984) (40)
- C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation. (1984) (40)
- Mechanisms of leukocyte regulation by complement-derived factors. (1984) (40)
- 1H NMR studies of human C3a anaphylatoxin in solution: sequential resonance assignments, secondary structure, and global fold. (1988) (39)
- Role of Chemotactic Factors in Neutrophil Activation After Thermal Injury in Rats (1999) (38)
- Intraluminal pancreatic serine protease activity, mucosal permeability, and shock: a review. (2006) (38)
- A protease‐sensitive site in the proposed Ca2+‐binding region of human serum amyloid P component and other pentraxins (1992) (38)
- The architecture of complement component C9 and poly(C9). (1985) (37)
- Activation of urinary kallikrein in patients with interstitial cystitis. (1994) (37)
- Cleavage of the Human C5A Receptor by Protienases Derived from Porphyromonas Gingivalis (1996) (37)
- REQUIREMENT FOR C5a IN LUNG VASCULAR INJURY FOLLOWING THERMAL TRAUMA TO RAT SKIN (1997) (36)
- Polymorphonuclear Leukocyte Behavior in a Nonhuman Primate Focal Ischemia Model (1994) (36)
- An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin. (1982) (36)
- Effects of the C5a anaphylatoxin and its relationship to cyclo‐oxygenase metabolites in rabbit vascular strips (1985) (35)
- Plasma lactoferrin reflects granulocyte activation via complement in burn patients. (1984) (35)
- Primary structure and functional characterization of rat C5a: An anaphylatoxin with unusually high potency (1994) (34)
- Complement activation and cytokine generation after modified Fontan procedure. (1998) (33)
- cDNA Cloning and Characterization of Rat C5a Anaphylatoxin Receptor (1997) (33)
- Complement activation in extracorporeal circulation: physiological and pathological implications. (1986) (33)
- The primary structure of porcine C3a anaphylatoxin. (1976) (32)
- Human C5a-related synthetic peptides as neutrophil chemotactic factors. (1979) (31)
- The release of elastase, myeloperoxidase, and lysozyme from human alveolar macrophages. (1982) (31)
- Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized. (1989) (31)
- Chemical aspects of the serum anaphylatoxins. (1978) (31)
- Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages. (1990) (30)
- Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. (1979) (30)
- Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a). (1978) (30)
- Influence of C3a anaphylatoxin compared to other vasoactive agents on the microcirculation of the rabbit omentum. (1975) (30)
- Serum carboxypeptidase B: a spectrophotometric assay using protamine as substrate. (1976) (29)
- High resolution proton magnetic resonance studies of cyanoferrimyoglobins and alkylated derivatives from different species. (1970) (28)
- Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues. (1984) (28)
- Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. (1985) (28)
- Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor. (1996) (28)
- Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock. (2004) (28)
- Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cell. (1985) (28)
- Sites of "spontaneous" degradation of IgD. (1977) (27)
- Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors. (1998) (27)
- Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock. (2001) (26)
- Chemotactic Factors Released in Culture by Intact Developing and Healing Skin Lesions Produced in Rabbits by the Irritant Sulfur Mustard (1997) (26)
- Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema. (1975) (25)
- Carboxymethylation of sperm whale myoglobin in the crystalline state. (1970) (25)
- Effects of the anaphylatoxin, C5a, on renal and glomerular hemodynamics in the rat. (1986) (25)
- Complement anaphylatoxin C5a stimulates release of SRS‐A‐like activity from guinea‐pig lung fragments (1980) (25)
- Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study. (2000) (25)
- Pancreatic Enzymes and Microvascular Cell Activation in Multiorgan Failure (2001) (24)
- Isolation of three separate anaphylatoxins from complement-activated human serum (1981) (23)
- The active site of human C4a anaphylatoxin. (1983) (23)
- Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1. (1982) (23)
- Complement-mediated arachidonate metabolism. (1985) (23)
- Evidence that the receptor for C4a is distinct from the C3a receptor. (1997) (23)
- Upper airway epithelial cells support eosinophil survival in vitro through production of GM-CSF and prostaglandin E2: regulation by glucocorticoids and TNF-alpha. (1999) (22)
- Characterization of human C4a anaphylatoxin. (1981) (22)
- Characterization of Two Classes of Pancreatic Shock Factors: Functional Differences Exhibited by Hydrophilic and Hydrophobic Shock Factors (2003) (22)
- Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells. (1982) (21)
- Characterization of leukotriene C4 synthetase in mouse peritoneal exudate cells. (1988) (21)
- Involvement of a tyrosine residue in the activity of bovine pancreatic deoxyribonuclease A. (1971) (21)
- Carboxymethylation of sperm whale myoglobin in the dissolved state. (1970) (21)
- Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins. (1986) (20)
- A New Paradigm of T Cell Allergy: Requirement for the B–1 Cell Subset (1999) (20)
- Mixed effects of TGF-β on human airway epithelial-cell chemokine responses (2000) (20)
- Protease inhibitors: novel therapeutic application and development. (1996) (20)
- Neutrophil Chemotactic Activity and C5a Following Systemic Activation of Complement in Rats (1997) (20)
- Anaphylatoxin-mediated regulation of human and murine immune responses. (1984) (19)
- Identification of ligand effector binding sites in transmembrane regions of the human G protein‐coupled C3a receptor (2008) (19)
- Complement activation and membrane lipids in lung vascular injury. (1987) (18)
- Circular dichroism studies of human factor H. A regulatory component of the complement system. (1982) (18)
- Bioactive complement fragments in immunoregulation. (1985) (18)
- A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. (1985) (18)
- Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop. (1998) (17)
- Mixed effects of TGF-beta on human airway epithelial-cell chemokine responses. (2000) (16)
- Contraction of guinea pig lung by synthetic oligopeptides related to human C3a. (1984) (16)
- Effects of complement fragments on pulmonary and vascular smooth muscle. (1987) (16)
- Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency (2004) (16)
- Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg. (1991) (15)
- Inability of the C3a anaphylatoxin to promote cellular lysis (1980) (15)
- Regulation of immune response by components of the complement cascade and their activated fragments (2004) (15)
- C5a receptor. (1987) (15)
- Molecular aspects of the serum chemotactic factors. (1979) (14)
- Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. (1986) (14)
- Possible role of serum anaphylatoxins in hypersensitivity reactions. (1981) (14)
- Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. (2000) (14)
- Site‐specific mutations in the N‐terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor (1993) (13)
- Suppression of humoral immune responses by synthetic C3a peptides. (1983) (13)
- Reactivity of the tryptophan residues in bovine pancreatic deoxyribonuclease with N-bromosuccinimide. (1980) (13)
- Effects of human anaphylatoxins on guinea pig atria. (1984) (13)
- Human C3a-mediated suppression of the immune response. II. Suppression of human in vitro polyclonal antibody responses occurs through the generation of nonspecific OKT8+ suppressor T cells. (1985) (13)
- Human prothrombin fragments FI(αβ) and F2: Preparation and characterization of structural and biological properties☆ (1980) (12)
- Mechanism of alternative complement pathway dysregulation by a phosphorothioate oligonucleotide in monkey and human serum. (2014) (12)
- Isolation and Characterization of a New and Highly Active form of C5a Anaphylatoxin from Epsilon-Aminocaproic Acid-Containing Porcine Serum (1973) (12)
- Initial Characterization of the Human Polymorphonuclear Leukocyte (PMN) C5a Receptor (1978) (12)
- The Preparation and Characterization of an Active Derivative of Bovine Pancreatic Deoxyribonuclease A Formed by Selective Cleavage with α-Chymotrypsin (1973) (11)
- Effect of structural modification at carbon atom 1 of leukotriene B4 on the chemotactic and metabolic response of human neutrophils. (1987) (11)
- Dietary aspartyl-phenylalanine-1-methyl ester delays osteoarthritis and prevents associated bone loss in STR/ORT mice. (2011) (11)
- Cellular receptors to the anaphylatoxins C3a and C5a. (1986) (11)
- THE CHEMISTRY AND BIOLOGY OF C3a, C4a, AND C5a AND THEIR EFFECTS ON CELLS (1983) (11)
- BIOACTIVE FACTORS OF THE BLOOD COMPLEMENT SYSTEM1 (1982) (10)
- C5a: a mediator of chemotaxis and cellular release reactions. (1981) (10)
- A Single Scheme for C3a and C5a Isolation and Characterization of Chemotactic Behavior (1976) (9)
- Functional significance of the subunits of carboxypeptidase N (kininase I). (1986) (9)
- Role of pancreatic enzymes in the development of multiple organ failure after shock (2008) (8)
- Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin. (1996) (8)
- PMN C5a-receptor down regulation is not involved in recovery from C5a-induced neutropenia. (1987) (8)
- Influence of free thiol group(s) on autoantibody-defined epitope of proliferating cell nuclear antigen. (1992) (7)
- Characterization of receptors to the anaphylatoxins on isolated cells. (1989) (7)
- Processing of C5a by human polymorphonuclear leukocytes (1998) (7)
- Uptake of C5a by polymorphonuclear leukocytes (PMNs) after focal cerebral ischemia. I. Effect of tirilazad mesylate intervention on C5a uptake by PMNs. (1994) (6)
- Structural characterization of the C4a anaphylatoxin from rat. (1988) (6)
- Cold-dependent activation of complement: Recognition, assessment, and mechanism (1992) (5)
- Selective Cleavage of Human C3 by Human Leukocyte Elastase (HLE) (1976) (5)
- Formation of leukotrienes C and D and Pharmacologic modulation of their synthesis. (1982) (5)
- Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity. (1999) (5)
- 196. Complement (C) activation by house dust extract: Implications in immediate hypersensitivity (1978) (4)
- Elevated kallikrein activity in plasma from stable liver transplant recipients. (2002) (4)
- Inflammatory Synthetic Peptides Related to C3a Anaphylatoxin (1978) (4)
- A preparation of λ phage DNA based on affinity chromatography (1993) (3)
- 257 Decreased leukotriene production by human peripheral blood mononuclear cells after aspirin ingestion (1983) (3)
- A new approach to designing active analogues of proteins. (1990) (3)
- The release of C5a in complement-activated serum does not require C6. (1989) (2)
- Degradation of C3a anaphylatoxins by rat mast cells (1986) (2)
- Leukocyte chemotaxis: A new in vivo testing technique (1977) (2)
- Cloning and characterization of the guinea pig C 5 a anaphylatoxin receptor : interspecies diversity among the C 5 a receptors (1998) (2)
- Role of complement anaphylatoxins in neutrophil arachidonic acid metabolism. (1985) (2)
- Plasma C3a and C4a levels in liver transplant recipients: A longitudinal study (1998) (2)
- Species and pathway-specific activation of complement by a phosphorothioate oligonucleotide (2000) (2)
- Histamine contamination of pokeweed mitogen. (1982) (2)
- Purification and Partial Characterization of Human and Porcine C 3 a Anaphylatoxin (2002) (2)
- Mechanisms for Microvascular Cell Activation: Pancreatic Digestive Enzyme Derived Inflammatory Mediators in Shock (2003) (1)
- Anaphylatoxin C3a induced mediator release from mast cells (1986) (1)
- Partial Characterization of Human C5a Anaphylatoxin (1976) (1)
- Effect of formyl peptide-toxin conjugates on myeloid cancer cell lines in vitro (1995) (1)
- Synthetic nonapeptide from C3d-K capable of inducing leukocytosis in rabbits and mice (1984) (1)
- Corrections - Designing Synthetic Superagonists of C3a Anaphylatoxin (1991) (1)
- Human prothrombin fragments F1 (alpha beta) and F2: preparation and characterization of structural and biological properties. (1980) (1)
- Circular Dichroism of C 3 a Anaphylatoxin (2002) (1)
- Immunobiology and Clinical Implications of the Complement-Derived Anaphylatoxins (1986) (1)
- Complement activation in EDTA blood/plasma samples may be caused by coagulation proteases (1997) (1)
- The preparation and characterization of an active derivative of bovine pancreatic deoxyribonuclease A formed by selective cleavage with alpha-chymotrypsin. (1973) (1)
- New standards for manuscripts on natural products. (2006) (1)
- Expression of Human C5a in E. Coli (1987) (1)
- Cardiovascular activating factors from the pancreas (1999) (0)
- Peripheral Blood Mononuclear Cells by C3a Regulation of IL-6 Synthesis in Human (1998) (0)
- Role of Cyclooxygenase Products and Tissue Macrophages (2005) (0)
- Contents, Vol. 66, Supplement 1, 1981 (1981) (0)
- Synthesis of COOH-terminal peptides from human C3a (1985) (0)
- Procedure Complement Activation and Cytokine Generation After Modified Fontan (2013) (0)
- Lipid cytotoxicity in shock may by mediated by lipid‐binding proteins (2006) (0)
- FragmentReceptor for the C5a Complement Activation Neuronal Expression of a Functional (2001) (0)
- Cellular proteases and control mechanisms : proceedings of a Glaxo-UCLA Colloquium on Cellular Proteases and Control Mechanisms, held at Lake Tahoe, California, February 21-26, 1988 (1989) (0)
- Contributions Contractile Effect of the Chemotactic Factors f-Met-Leu-Phe and C 5 a on the Human Isolated Umbilical Artery Role of Cyclooxygenase Products and Tissue Macrophages (2005) (0)
- to Early T Cell Recruitment Elicitation of Contact Sensitivity by Leading Early Local Generation of C5a Initiates the (2000) (0)
- A rapid radioassay and some properties for leukotriene C4 synthase. (1993) (0)
- (biologically active peptides/chemotatic peptides/glycopeptides) (2016) (0)
- Structural Changes Accompanying Enzymatic Activation of (2017) (0)
- Cytotoxic effect of radiolabeled C5a on U937 cells in vitro. (1996) (0)
- Traffics in splanchnic microcirculation : a new hypothesis for origin of shock and multi-organ failure due to pancreatic enzymes (2003) (0)
- Analysis of Trigger Mechanisms for Inflammation in Cardiovascular Disease: Application to Shock and Multiorgan Failure (2005) (0)
- Gut intraluminal pancreatic protease inhibition limits resuscitation requirements after hemorrhagic shock (2006) (0)
- Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C 5 a is independent of phospholipase activation ( chemotactic factors / arachidonic acid / lipoxygenase / chemotaxis / human neutrophils ) (1999) (0)
- International Immunopharmacology: Editorial (2001) (0)
- KINDRED WITH HEREDITARY ANGIONEUROTIC EDEMA (0)
- From Molecular Science to the Treatment of Allergy (1999) (0)
- INHIBITION OF ENTERAL ENZYME WITH FUTHAN REDUCES MESENTERIC LYMPH-INDUCED ENDOTHELIAL CELL DEATH (2006) (0)
- PANCREATIC NEUTROPHIL ACTIVATORS IN SAO SHOCK (1999) (0)
- STRUCTURAL CHARACTERIZATION OF THE C 4 a ANAPHYLATOXIN FROM RAT (2002) (0)
- ANALYSIS OF TRIGGER MECHANISMS FOR SHOCK AND MULTI‐ORGAN FAILURE: SELF‐DIGESTION BY PANCREATIC DIGESTIVE ENZYMES AND A NEW CLASS OF INFLAMMATORY MEDIATORS: 326 (2004) (0)
- Methods in Enzymology, Robert C. Murphy, Frank A. Fitz-Patrick (Eds.), in: Arachidonate Related Lipid Mediators, 187. Academic Press, San Diego, CA (1990), 683 (1991) (0)
- Extracellular Loop Alternative Splicing in the Large Guinea Pig C 3 a Anaphylatoxin Receptor : Molecular Cloning of Two Isoforms of the (1998) (0)
- A preparation of lambda phage DNA based on affinity chromatography. (1993) (0)
- Associate Editor Dr. Fred L. Pearce to Retire from International Immunopharmacology (2006) (0)
- The numerous proinflammatory functions of C5a (1998) (0)
- C 4 a : The third anaphylatoxin of the human complement system ( phlogogenic peptides / C 3 a and C 5 a anaphylatoxins / structural homology / cell surface receptors ) (0)
- An amphiphilic structure of c9: evidence from analysis of c9 fragments produced byα-thrombin (1982) (0)
- Processing of C5a by human neutrophils (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Tony E. Hugli?
Tony E. Hugli is affiliated with the following schools:
